Pharmafile Logo
Pharmafocus logo
Advanced Search
ABPI image

ABPI slams NICE International

August 20, 2012
Sales and Marketing ABPI, NICE, NICE International, Romania, hta

The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …

News

Pharma manufacturing news in brief

August 20, 2012
Manufacturing and Production, Sales and Marketing Cambrex, GSK, Laureate, Morphotek

GlaxoSmithKline says it has shut down one of its two manufacturing facilities in India after offering all workers there early …

News
Roche image

Roche winning on Perjeta supply, but running short of Boniva

August 20, 2012
Manufacturing and Production, Sales and Marketing Boniva, Perjeta, Roche, breast cancer

Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but …

News

Hospira hit by yet another product recall

August 20, 2012
Manufacturing and Production, Sales and Marketing Carpuject, Hospira, overdose, recall

Generic pharma company Hospira has been forced to recall another product as it works to rectify quality issues at three …

News

Claris LifeSciences gets clean bill of health from FDA

August 20, 2012
Manufacturing and Production, Sales and Marketing Claris, FDA, Pfizer, sterile

Indian drugmaker Claris LifeSciences seems to have set its house in order after manufacturing issues led the FDA to impose …

News

GSK severe asthma drug progresses to Phase III

August 20, 2012
Research and Development, Sales and Marketing Advair, GSK, Phase II, asthma, phase III

GlaxoSmithKline’s severe asthma drug mepolizumab has impressed in a mid-stage study, meaning it can now progress into Phase III testing. …

News
Takeda's Actos

Generic Actos gains FDA approval

August 20, 2012
Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic

Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …

News

Euro RSCG Life UK expands account services team

August 17, 2012
Medical Communications Euro RSCG Life UK, Havas, Lucretia King

Euro RSCG Life UK, a leading healthcare communications network, is pleased to announce the appointment of Lucretia King as client …

News

Reynolds-MacKenzie appoints new leadership team

August 17, 2012
Medical Communications Reynolds-Mackenzie

Reynolds-MacKenzie has made two new senior hires and an internal promotion to help drive its UK and international operations. The …

News
McCann

IPA Best of Health 2012 Awards highlights

August 17, 2012
Medical Communications Best of Health, IPA, IPA Best of Health Awards, McCann Torre Lazur, advertising

McCann Torre Lazur and The Cement Bloc were awarded the prestigious ‘Best of Show’ awards at the 2012 IPA Best …

Feature
Xgeva image

Xgeva gains NICE recommendation for bone metastasis

August 17, 2012
Sales and Marketing Amgen, NICE, Xgeva, bone metastatis

NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …

News

Zaicom MMC appoints new medical writer

August 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Katharine Peregrín, Zaicom MMC

Comms agency Zaicom MMC, part of the Zaicom International group of companies, has appointed Katharine Peregrín as a medical writer.  …

Appointment
Novartis image

Novartis eye drug succeeds in Phase III trial

August 16, 2012
Sales and Marketing FDA, Novartis, Ocriplasmin, Roche, VMA

Novartis has posted positive results for its investigational eye drug ocriplasmin. The Phase III study found that ocriplasmin significantly resolved …

News
Pfizer image

Pfizer meets targets on greenhouse gases

August 16, 2012
Manufacturing and Production GHGs, Merck, Pfizer

Pfizer says it has fulfilled its goal of cutting environmentally-harmful emissions from its facilities by 20%, a year ahead of …

News

The number one reason for a failed project

August 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Communication, Failed project, Les Rose, clinical trials

There was once a company that had an amusing form of words for admonishing people. It went something like this: …

Feature

Boehringer posts strong financials

August 16, 2012
Sales and Marketing AMNOG, Boehringer, COPD, Spiriva

Boehringer Ingelheim has seen steady growth in the first half of 2012, but warns that the next six months may …

News

Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka and Extensive Investments to Zydis® Technology Capabilities in Swindon, UK

August 16, 2012
Manufacturing and Production

Somerset, NJ, July 24, 2012 – Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD …

News
Press release

Catalent and Bend Research Partner to Provide Integrated Solutions for Oral Controlled-Release Technologies

August 16, 2012
Manufacturing and Production

Catalent Pharma Solutions, Inc. and Bend Research Inc. have entered into an agreement to provide integrated solutions for pharmaceutical companies …

News
Press release

Diabetes prescriptions jump by 50% in England

August 15, 2012
Sales and Marketing Humalog, Januvia, NHS, diabetes, spending

Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …

News
GSK HQ

GSK sheds Australian generics unit for £172m

August 15, 2012
Sales and Marketing Aspen Global, GSK, generics

GlaxoSmithKline has divested the majority of its Australian generics unit to Aspen Global, a firm it partly owns. The South …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026